S

    Sanara Medtech Inc (SMTI)

    Official site

    HEALTHCARE • MEDICAL INSTRUMENTS & SUPPLIES • NASDAQ

    $34.88
    +0.31 (+0.90%)

    Market Cap: $317.63M

    Last updated: Sep 01, 2026 at 10:00 AM ET

    Earnings

    Performance (10Y)

    Beat Rate
    41%(9/22)
    Avg Surprise
    -109.12%
    Streak
    1 Q

    Upcoming Estimates

    Sep 30, 2026
    EPS Consensus$0.02
    Range$0.02 - $0.02
    1 analysts
    EPS RevisionsNo revisions (7d)No revisions (30d)
    EPS Estimate Drift
    90d ago$0.08+300.0%
    60d ago$0.02+0.0%
    30d ago$0.02+0.0%
    7d ago$0.02+0.0%
    Current$0.02
    Revenue Consensus
    $30M
    Range$30M - $30M
    2 analysts
    Dec 31, 2026
    EPS Consensus$0.47
    Range$0.47 - $0.47
    1 analysts
    Revenue Consensus
    $31M
    Range$31M - $31M
    1 analysts
    PeriodReportedEst.SurpriseB/MYoY
    Dec 26EST
    		-$0.47---
    Sep 26EST
    		-$0.02---
    Jun 26
    		$0.05$0.02+150.00%Beat+121.7%
    Mar 26
    		$0.04N/A-87.69%Miss+109.8%
    Dec 25
    		$-0.19$0.11-272.73%Miss-5.6%
    Sep 25
    		$-3.52$-0.21-1576.19%Miss-935.3%
    Jun 25
    		$-0.23$-0.44+47.73%Beat+43.9%
    Mar 25
    		$-0.41$-0.50+18.00%Beat-95.2%
    Dec 24
    		$-0.18$-0.12-56.52%Miss-500.0%
    Sep 24
    		$-0.34$-0.62+45.16%Beat-161.5%
    Jun 24
    		$-0.41$-0.21-95.24%Miss-86.4%
    Mar 24
    		$-0.21$-0.07-200.00%Miss-50.0%
    Dec 23
    		$-0.03N/A+76.92%Beat+92.1%
    Sep 23
    		$-0.13$-0.04-225.00%Miss+27.8%
    Jun 23
    		$-0.22$-0.13-69.23%Miss+47.6%
    Mar 23
    		$-0.14N/A+57.58%Beat+65.9%
    Dec 22
    		$-0.38$-0.26-46.15%Miss+20.8%
    Sep 22
    		$-0.18$-0.32+43.75%Beat+33.3%
    Jun 22
    		$-0.42$-0.28-50.00%Miss-162.5%
    Mar 22
    		$-0.41$-0.41+0.00%Beat-141.2%
    Dec 21
    		$-0.48$-0.27-77.78%Miss-1100.0%
    Sep 21
    		$-0.27$-0.18-50.00%Miss-50.0%
    Jun 21
    		$-0.16$-0.12-33.33%Miss+11.1%
    Mar 21
    		$-0.17$-0.17+0.00%Beat+56.4%
    Dec 20
    		$-0.04$0.00N/ABeat+90.9%
    Sep 20
    		$-0.18N/AN/ABeat+48.6%
    Jun 20
    		$-0.18N/AN/ABeat-20.0%
    Mar 20
    		$-0.39N/AN/ABeat+0.0%
    Dec 19
    		$-0.44N/AN/ABeat-540.5%
    Sep 19
    		$-0.35N/AN/ABeat-480.0%
    Jun 19
    		$-0.15N/AN/ABeat-1600.0%
    Mar 19
    		$-0.39N/AN/ABeat-4000.0%
    Dec 18
    		$-0.07N/AN/ABeat-271.8%
    Sep 18
    		$0.09N/AN/ABeat+121.4%
    Jun 18
    		$0.01N/AN/ABeat+112.2%
    Mar 18
    		$0.01N/AN/ABeat-67.2%
    Dec 17
    		$0.04N/AN/ABeat+107.3%
    Sep 17
    		$0.04N/AN/ABeat+2289.5%
    Jun 17
    		$-0.08N/AN/ABeat-
    Mar 17
    		$0.03N/AN/ABeat-
    Dec 16
    		$0.02N/AN/ABeat-
    Sep 16
    		$-0.00N/AN/ABeat-

    Key Metrics

    Valuation
    P/E Ratio-9.64EV/EBITDA35.48x
    Price/FCF67.09xFCF Yield1.49%
    Profitability
    Profit Margin-29.10%Operating Margin6.33%
    ROE-1.32%ROIC19.89%
    Financial Health
    Debt/Equity5.93xInterest Coverage1.91x
    Current Ratio2.58xQuick Ratio2.30x
    Trading Statistics
    Beta1.16Avg Volume330.41K
    52-Week High$35.9552-Week Low$16.05

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$34.49
    SMA 20$34.32
    SMA 50$29.08
    SMA 200$22.95
    EMA 10$34.45
    EMA 20$33.51
    EMA 50$30.10
    EMA 200$25.65

    MACD

    Line: 1.54Signal: 1.86Hist: -0.32

    ADX

    ADX: 58.0+DI: 36.8-DI: 9.0

    Aroon & PSAR

    Aroon Up100.0
    Aroon DownN/A
    PSAR$34.46

    Bollinger Bands

    Upper Band$34.81
    Lower Band$33.84
    %B Position283%(Upper)
    Band Width1.07

    RSI (14-Day)

    Overbought
    80.4

    Momentum Oscillators

    Stoch %K82.6
    Stoch %D82.4
    Williams %R-4.3
    ROC (10d)2.6%
    Momentum0.88
    CCI (20d)161.5
    MFI (14d)57.3

    Volatility Measures

    ATR (14d)$0.55(1.6%)
    StdDev (20d)0.24
    Hist Vol6.2%(Low)

    Volume Flow

    VWAP$34.77
    OBV2.8M
    AD Line2.6M
    CMF (20d)0.276

    Volume Metrics

    Avg Vol (20d)329.9K
    Vol Ratio0.8x
    VWMA (20d)$34.31

    Pivot Points

    R3$35.03
    R2$34.90
    R1$34.73
    Pivot Point$34.60
    S1$34.43
    S2$34.30
    S3$34.13

    Advanced Oscillators

    TSI60.85
    Ultimate Osc62.2
    KST239.94

    Financial Data

    QuarterJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Total Revenue$28.14M$27.80M$27.52M$26.33M$25.80M$23.43M$26.31M$21.67M$20.16M$18.54M$17.69M$16.02M
    Cost of Revenue$1.98M$1.92M$1.87M$1.87M$1.94M$1.83M$2.25M$1.99M$2.01M$1.89M$1.79M$1.75M
    Gross Profit$26.16M$25.87M$25.64M$24.46M$23.87M$21.60M$24.06M$19.68M$18.15M$16.65M$15.90M$14.27M
    Operating Expenses$24.38M$23.23M$19.18M$21.52M$21.38M$20.77M$19.15M$18.90M$21.05M$18.18M$16.13M$15.18M
    R&D$1.15M$759,592$1.67M$1.03M$1.06M$950,359$112,874$783,840$985,651$946,298$651,519$986,454
    SG&A$22.60M$21.88M$15.85M$19.88M$19.63M$19.13M$19.10M$17.42M$18.96M$16.19M$16.34M$13.88M
    Operating Income$1.78M$2.65M$6.47M$2.94M$2.49M$825,530$4.90M$778,537$-2,884,856$-1,531,707$-225,995$-906,655
    Interest Income$-379,834$-449,549$-324,734$-288,642$-195,482$-139,936$-36,581$-31,448$0$0$0$0
    Interest Expense$1.81M$1.80M$1.83M$1.82M$1.79M$1.32M$1.29M$927,577$644,346$267,336$287,483$188,294
    Income Before Tax$-411,144$397,687$4.33M$834,493$500,259$-620,566$3.57M$-180,488$-3,529,202$-1,799,043$-262,444$-1,094,949
    Income Tax Expense$0$0$0$0$0$0$0$0$0$0$0$0
    Net Income$-452,864$458,603$-1,610,158$-30,412,108$-2,018,398$-3,527,383$-1,700,601$-2,883,052$-3,529,202$-1,799,043$-262,444$-1,094,949
    EBITDA$2.47M$3.31M$7.22M$4.05M$3.68M$2.02M$6.56M$1.93M$-1,681,549$-423,204$871,871$93,074
    EBIT$1.78M$2.65M$6.47M$2.94M$2.49M$836,462$4.90M$778,537$-2,884,856$-1,531,707$-225,995$-906,655
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about SMTI

    News

    INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sanara MedTech, Inc. - SMTI

    Pomerantz LLP is investigating potential securities fraud claims against Sanara MedTech, Inc. (SMTI) on behalf of investors. The investigation stems from Sanara's November 2025 announcement to discontinue its Tissue Health Plus program, leading to a significant net loss and asset impairment charge. This news caused Sanara's stock price to drop by 24.7%.

    Eastern Progress•8/23/26•
    Bearish

    INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sanara MedTech, Inc. - SMTI

    Pomerantz LLP is investigating potential securities fraud claims against Sanara MedTech, Inc. (SMTI) following a significant stock drop. The investigation centers on Sanara's decision to discontinue its Tissue Health Plus (THP) program in November 2025, which resulted in a $31.2 million net loss from discontinued operations, primarily due to a $26.5 million asset impairment charge. Sanara's stock price subsequently fell by 24.7% on November 12, 2025.

    Eastern Progress•8/22/26•
    Bearish

    Sanara MedTech Inc. (NASDAQ:SMTI) Short Interest Update

    Sanara MedTech Inc. (NASDAQ:SMTI) experienced a significant 42.8% decrease in short interest in July, totaling 216,090 shares, which represents 4.1% of outstanding shares and less than one day of average trading volume. This update follows a period of weakening analyst sentiment, with several downgrades leading to a consensus "Reduce" rating and an average price target of $35.00. The company also recently missed quarterly earnings expectations, reporting a loss of $0.05 per share against an anticipated $0.02 loss and revenue below estimates.

    MarketBeat•8/17/26•
    Bearish

    Walleye Capital LLC Makes New $719,000 Investment in Sanara MedTech Inc. $SMTI

    Walleye Capital LLC has made a new investment of $719,000 in Sanara MedTech Inc. (NASDAQ:SMTI), acquiring 30,465 shares, which represents about 0.33% of the company. Despite institutional investors collectively owning 8.10% of SMTI, analyst sentiment has weakened with several downgrades to "Hold" or "Neutral," and the company recently missed quarterly earnings and revenue estimates. Sanara MedTech specializes in medical technology for ear, nose, and throat healthcare, focusing on minimally invasive sinus dilation systems.

    MarketBeat•8/16/26•
    Somewhat-Bearish

    Sanara MedTech (SMTI) Stock Stays Quiet As Profitability Meets Debt Scrutiny

    Sanara MedTech (SMTI) recently turned profitable in Q2 2026, reporting net income of US$0.40m from continuing operations, a significant improvement from a loss in the prior year. Despite this positive shift and increased revenue, the stock's reaction was muted, with concerns remaining over thin interest coverage levels and the company's balance sheet strength. Analysts are now scrutinizing whether this new profitability can be sustained against existing debt challenges.

    Sahm•8/14/26•
    Neutral

    Frequently Asked Questions About SMTI

    Does SMTI pay dividends?
    Sanara Medtech Inc (SMTI) does not currently pay a regular dividend.
    What is SMTI's market cap?
    Sanara Medtech Inc (SMTI) has a market capitalization of $317.63M with a current stock price of $34.88.

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In